Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Knowledge of professionals about sexuality of the ostomyzed.
Rodríguez-Maldonado Y, Juan TS, Hermosa AR, Naranjo-Peña I, Gea-López V, Cambronero-Santos J. Rodríguez-Maldonado Y, et al. Among authors: cambronero santos j. Cir Cir. 2023;91(4):528-534. doi: 10.24875/CIRU.22000153. Cir Cir. 2023. PMID: 37677936 Free article. English.
Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study.
Herschorn S, McVary KT, Cambronero Santos J, Foley S, Kristy RM, Choudhury N, Hairston J, Kaplan SA. Herschorn S, et al. Among authors: cambronero santos j. Urology. 2021 Jan;147:235-242. doi: 10.1016/j.urology.2020.09.040. Epub 2020 Oct 10. Urology. 2021. PMID: 33045287 Free article. Clinical Trial.
Reply by Authors.
Kaplan SA, Herschorn S, McVary KT, Staskin D, Chapple C, Foley S, Cambronero Santos J, Kristy RM, Choudhury N, Hairston J, Schermer CR. Kaplan SA, et al. Among authors: cambronero santos j. J Urol. 2020 Jun;203(6):1171. doi: 10.1097/JU.0000000000000738.02. Epub 2020 Mar 19. J Urol. 2020. PMID: 32191170 No abstract available.
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).
Kaplan SA, Herschorn S, McVary KT, Staskin D, Chapple C, Foley S, Cambronero Santos J, Kristy RM, Choudhury N, Hairston J, Schermer CR. Kaplan SA, et al. Among authors: cambronero santos j. J Urol. 2020 Jun;203(6):1163-1171. doi: 10.1097/JU.0000000000000738. Epub 2020 Jan 2. J Urol. 2020. PMID: 31895002 Clinical Trial.
Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE).
Drake MJ, MacDiarmid S, Chapple CR, Esen A, Athanasiou S, Cambronero Santos J, Mitcheson D, Herschorn S, Siddiqui E, Huang M, Stoelzel M. Drake MJ, et al. Among authors: cambronero santos j. Int J Clin Pract. 2017 May;71(5):e12944. doi: 10.1111/ijcp.12944. Epub 2017 Apr 16. Int J Clin Pract. 2017. PMID: 28419650 Free PMC article. Clinical Trial.
[Expert opinion about the use of transdermic oxybutynin in Spain for the treatment of adult overactive bladder.].
Müller-Arteaga C, Arlandis Guzmán S, Lorenzo Gómez MF, Errando-Smet C, González López R, Cambronero Santos J, Gutiérrez Baños JL, Sánchez Marcos M, Ortiz Gamiz A, Merino Salas S, Martínez Rodriguez R, Olano Grasa I. Müller-Arteaga C, et al. Among authors: cambronero santos j. Arch Esp Urol. 2016 Nov;69(9):613-620. Arch Esp Urol. 2016. PMID: 27845692 Spanish.
[Laparoscopy in retroperitoneal fibrosis].
Fariña Pérez LA, dos Santos J, Cambronero Santos J, Zungri Telo ER. Fariña Pérez LA, et al. Among authors: cambronero santos j. Actas Urol Esp. 2005 Apr;29(4):434-5. doi: 10.1016/s0210-4806(05)73269-1. Actas Urol Esp. 2005. PMID: 15981436 Spanish. No abstract available.
[Radio-opaque lithiasis and indinavir].
Fariña Pérez LA, Martínez MC, dos Santos J, Cambronero Santos J. Fariña Pérez LA, et al. Among authors: cambronero santos j. Actas Urol Esp. 2005 Jan;29(1):120. doi: 10.1016/s0210-4806(05)73214-9. Actas Urol Esp. 2005. PMID: 15786779 Spanish. No abstract available.
16 results